Pharmaceuticals, GSK will invest in Siena
GlaxoSmithKline, the pharmaceuticals giant that generates approximately 1.5 billion Euros of turnover in Italy, lands in Tuscany, and promises to invest in Siena and the vaccines division.
GlaxoSmithKline, the pharmaceuticals giant that generates approximately 1.5 billion Euros of turnover in Italy, lands in Tuscany, and promises to invest in Siena and the vaccines division.
The port of Livorno wagers on private investors for its relaunch. At the end of the summer, the Port of Livorno Authority, the public office that controls the Tuscan port, will begin its search for a stockholding partner by initiating a tender whose objective is ceding a considerable portion of the capital
Has the hour for the turning point come? The improved expectations for the 2014 turnover, the recovery of internal demand and the first prudent investment programs seem to provide an affirmative response
With a total energy production of 875 MW, Italy is the world’s fifth largest producer of geothermal energy – after the United Sates, the Philippines, Indonesia and Mexico – and Europe’s largest producer of underground energy
A research project developed by the University of Pisa has developed a “shield” against such weapons, placing biotechnology at the heart of the battle against toxic substances.
The Tuscan garment, footwear and leather businesses are among Italy’s top districts